Pharmacokinetic Evaluation of Brain Penetrating Morpholine-3-hydroxy-2-pyridine Oxime as an Antidote for Nerve Agent Poisoning
- 27 February 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 11 (7) , 1072-1084
Abstract
Nerve agents, the deadliest chemical warfare agents, are potent inhibitors of acetylcholinesterase (AChE) and cause rapid cholinergic crisis with serious symptoms of poisoning. Oxime reactivators of AChE are used in medical practice in treatment of nerve agent poisoning, but the search for novel improved reactivators with central activity is an ongoing pursuit. Among the numerous oximes synthesized, in vitro reactivation is a standard approach in biological evaluation with little attention given to the pharmacokinetic properties of the compounds. This study reports a comprehensive physicochemical, pharmacokinetic, and safety profiling of five 3-hydroxy-2-pyridine aldoximes, which were recently shown to be potent AChE reactivators. The oxime JR595 was singled out as highly metabolically stable in human liver microsomes and non-cytotoxic oxime for SH-SY5Y neuroblastoma and 1321N1 astrocytoma cell lines and its pharmacokinetic profile was determined after intramuscular administration in mice. JR595 was rapidly absorbed into blood after 15 min with simultaneous distribution to the brain at up to about 40% of its blood concentration; however, it was eliminated both from the brain and blood within an hour. In addition, the MDCKII-MDR1 cell line assay showed that oxime JR595 was not a P-glycoprotein efflux pump substrate. Furthermore, preliminary antidotal study against multiple LD50 doses of VX and sarin in mice showed the potential of JR595 to provide desirable therapeutic outcomes with future improvements in its circulation time.Keywords
Funding Information
- Agence Nationale de la Recherche (ANR-11-LABX-0029, ANR-17-CE39-0012)
- Universit? de Rouen
- Direction G?n?rale de l?Armement
- Centre National de la Recherche Scientifique
- Hrvatska Zaklada za Znanost (33068WE, IP-2013-11-4307, IP-2018-01-7683, UIP-2017-05-7260)
- Institut national des sciences appliqu?es de Rouen
- Ambassade de France ? Zagreb (33068WE)
This publication has 62 references indexed in Scilit:
- Acetylcholinesterase Reactivators (HI-6, Obidoxime, Trimedoxime, K027, K075, K127, K203, K282): Structural Evaluation of Human Serum Albumin Binding and Absorption KineticsInternational Journal of Molecular Sciences, 2013
- Refinement of Structural Leads for Centrally Acting Oxime Reactivators of Phosphylated CholinesterasesJournal of Biological Chemistry, 2012
- Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticityDrug Discovery Today, 2011
- New Structural Scaffolds for Centrally Acting Oxime Reactivators of Phosphylated CholinesterasesJournal of Biological Chemistry, 2011
- First efficient uncharged reactivators for the dephosphylation of poisoned human acetylcholinesteraseChemical Communications, 2011
- Reactivation of brain acetylcholinesterase by monoisonitrosoacetone increases the therapeutic efficacy against nerve agents in guinea pigsChemico-Biological Interactions, 2010
- Structure and function of the blood–brain barrierNeurobiology of Disease, 2010
- Effect of acetylcholinesterase oxime-type reactivators K-48 and HI-6 on human liver microsomal cytochromes P450 invitroChemico-Biological Interactions, 2009
- Interactions of butane, but-2-ene or xylene-like linked bispyridinium para-aldoximes with native and tabun-inhibited human cholinesterasesChemico-Biological Interactions, 2008
- Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitorsBiochemistry, 1993